PCMI
SGMO

Princeton Capital Management Inc’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Princeton Capital Management Inc’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-44,250
Closed -$135K – 69
2016
Q4 		$135K Sell
44,250
-62,895
-59% -$229K 0.09% 63
2016
Q3 		$496K Sell
107,145
-17,250
-14% -$87.7K 0.32% 55
2016
Q2 		$720K Hold
124,395
– – 0.5% 45
2016
Q1 		$753K Sell
124,395
-3,000
-2% -$18K 0.52% 44
2015
Q4 		$1.16M Buy
127,395
+5,950
+5% +$45.8K 0.82% 38
2015
Q3 		$685K Buy
121,445
+7,325
+6% +$60.4K 0.41% 44
2015
Q2 		$1.27M Hold
114,120
– – 0.67% 39
2015
Q1 		$1.79M Buy
114,120
+1,580
+1% +$24.4K 0.92% 37
2014
Q4 		$1.71M Buy
112,540
+9,775
+10% +$119K 0.95% 38
2014
Q3 		$1.11M Buy
102,765
+4,000
+4% +$52.2K 0.71% 42
2014
Q2 		$1.51M Buy
98,765
+22,815
+30% +$328K 1.04% 36
2014
Q1 		$1.37M Buy
75,950
+13,700
+22% +$264K 1% 37
2013
Q4 		$865K Sell
62,250
-4,700
-7% -$54.1K 0.69% 45
2013
Q3 		$702K Buy
66,950
+50,450
+306% +$501K 0.64% 44
2013
Q2 		$129K Buy
+16,500
New +$144K 0.12% 68

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
FC
FIC Capital New York $262M AUM 34.37% 1-Year Est. Return

Princeton Capital Management Inc's SGMO Position: Q1 2017 in Review

Princeton Capital Management Inc sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2017, closing a stake of 44,250 shares — an estimated $135K sold.

Princeton Capital Management Inc first reported a position in SGMO in Q2 2013 and held it in 15 quarters. The position peaked at $1.79M in Q1 2015. 118 funds tracked by Wall St. Rank hold SGMO as of Q1 2017.

  • Princeton Capital Management Inc reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2017 after selling out during the quarter.
  • Princeton Capital Management Inc sold 44,250 SANGAMO THERAPEUTICS INC shares in Q1 2017, an estimated $135K.
  • Princeton Capital Management Inc first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 15 quarters.
  • Princeton Capital Management Inc's SANGAMO THERAPEUTICS INC position peaked at $1.79M in Q1 2015.
  • 118 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2017.

Based on Princeton Capital Management Inc's 13F filing for Q1 2017, filed 10 May 2017.